Several studies have shown that soluble cell surface receptors like platelet-derived growth factor receptor and epidermal growth factor receptor can be detected in both conditioned media from cancer cells and patient plasma; however, it has not been clearly demonstrated whether these soluble cell surface receptors in the plasma are actually originated from the tumor cells [16], [34], [35]. The gene discussed is CD177; the disease is cancer.